Regencell Bioscience Holdings Ltd announced a registered direct offering of 985,222 ordinary shares priced at $20.30 each, expecting gross proceeds of approximately $20 million, with the transaction closing around May 20, 2026.
AI Assistant
REGENCELL BIOSCIENCE HOLDINGS LTD
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.